QQ客服 官方微博 反馈留言

浏览/检索结果: 共4条，第1-4条 帮助 限定条件 学科主题：Pharmacology & Pharmacy     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择发表日期升序发表日期降序提交时间升序提交时间降序题名升序题名降序作者升序作者降序 Hybrid pyrimidine alkynyls inhibit the clinically resistance related Bcr-Abl(T315I) mutant 期刊论文 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 卷号: 25, 期号: 17, 页码: 3458-3463 作者:  Ding, Ke;  Pan, Xiaofeng;  Wang, Deping;  Zhuang, Xiaoxi;  Luo, Jingfeng 收藏  |  浏览/下载：22/0  |  提交时间：2018/12/13 Hybrid pyrimidine alkynyls inhibit the clinically resistance related Bcr-Abl(T315I) mutant 期刊论文 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 卷号: 25, 期号: 17, 页码: 3458-3463 Lu, Xiaoyun; Zhang, Zhang; Ren, Xiaomei; Pan, Xiaofeng; Wang, Deping; Zhuang, Xiaoxi; Luo, Jingfeng; Yu, Rongmin; Ding, Ke 收藏  |  浏览/下载：22/0  |  提交时间：2016/12/16 Identification of GZD824 as an Orally Bioavailable Inhibitor That Targets Phosphorylated and Nonphosphorylated Breakpoint Cluster Region-Abelson (Bcr-Abl) Kinase and Overcomes Clinically Acquired Mutation-Induced Resistance against Imatinib 期刊论文 JOURNAL OF MEDICINAL CHEMISTRY, 2013, 卷号: 56, 期号: 3 作者:  Wang, Deping;  Feng, Yubing;  Zhuang, Xiaoxi;  Zhang, Fengxiang;  Liu, Jianqi 收藏  |  浏览/下载：23/0  |  提交时间：2018/12/13 Identification of GZD824 as an Orally Bioavailable Inhibitor That Targets Phosphorylated and Nonphosphorylated Breakpoint Cluster Region-Abelson (Bcr-Abl) Kinase and Overcomes Clinically Acquired Mutation-Induced Resistance against Imatinib 期刊论文 JOURNAL OF MEDICINAL CHEMISTRY, 2013, 卷号: 56, 期号: 3 Ren, Xiaomei; Pan, Xiaofen; Zhang, Zhang; Wang, Deping; Lu, Xiaoyun; Li, Yupeng; Wen, Donghai; Long, Huoyou; Luo, Jinfeng; Feng, Yubing; Zhuang, Xiaoxi; Zhang, Fengxiang; Liu, Jianqi; Leng, Fang; Lang, Xingfen; Bai, Yang; She, Miaoqin; Tu, Zhengchao; Pan, Jingxuan; Ding, Ke 收藏  |  浏览/下载：23/0  |  提交时间：2016/12/16